跳至主要内容
临床试验/NL-OMON45786
NL-OMON45786已完成不适用

Investigation of plaque vulnerability: Identification of atherosclerotic plaque angiogenesis using Bevacizumab-800CW and optoacoustic imaging: a single center proof of concept study (CAROTID-OPTOLIGHT) - Carotid Optolight

niversitair Medisch Centrum Groningen0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational non invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Patients with significant and symptomatic carotid stenosis who are scheduled for carotid endarterectomy as decided by the Multi-Disciplinary Carotid Board

排除标准

  • 1) Medical or psychiatric condition that compromise the patient*s ability to give informed consent
  • 2) Pregnant or lactating women
  • 3) Significant renal (creatinine >110 µmol/L) dysfunction
  • 4) History of iodine allergy or anaphylactic reactions to insect bites or medication or previous allergic reaction to bevacizumab
  • 5) Presence or history of hyperthyroidism

研究者

相似试验